Purpose: To assess whether changes in diffusionweighted MRI (DW-MRI) and 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT), correlate with treatment response to neoadjuvant therapy (NT), as expressed by tumor regression grade (TRG), from locally advanced gastric adenocarcinoma (GA).
Materials and Methods: Seventeen patients underwent both DW-MRI and 18F-FDG-PET/CT scans before and after the end of NT. Apparent diffusion coefficient (ADC) and mean standardized uptake value (SUV) corrected for partial volume effect (PVC-SUVBW-mean) were evaluated and compared with histopathological TRG.
Results: Pre- And post-NT and percentage changes forADC and PVC-SUVBW-mean were assessed. Post-NT ADC and DADC showed a significant inverse correlation with TRG (r=-0.71; P=0.0011 and r=-0.78; P=0.00020, respectively) and significant differences in their mean values were found between responders (TRG 1-2-3) and nonresponders (TRG 4-5) (P=0.0009; P=0.000082, respectively). No correlations with TRG were found for pre-NT ADC and for all PVC-SUVBW-mean values as well as between DADC and D PVC-SUVBW-mean.
Conclusion: DW-MRI seems more accurate than 18FFDG-PET/CT and ADC modifications may represent a reproducible tool to assess tumor response for GA.
- Gastric cancer
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging